Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus
- PMID: 14651331
Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus
Abstract
Dyslipidaemia, hallmarked by low HDL cholesterol and high plasma triglycerides, is a feature of insulin resistance and type 2 diabetes mellitus. These lipoprotein abnormalities represent major cardiovascular risk factors in these conditions. Among other factors, lipoprotein lipase (LPL), hepatic lipase (HL), lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) play an important role in an abnormal HDL metabolism in insulin resistance and type 2 diabetes mellitus. LPL hydrolyses lipoprotein triglycerides, thus providing lipids for HDL formation. In insulin resistant states, a decreased post-heparin plasma LPL activity contributes to a low HDL cholesterol, whereas an increased activity of HL reduces HDL particle size by hydrolysing its triglycerides and phospholipids. High HL activity coincides with low HDL cholesterol. The esterification of free cholesterol by LCAT increases HDL particle size. Subsequent CETP action results in transfer of cholesteryl esters from HDL towards triglyceride-rich lipoproteins. This cholesteryl ester transfer process results in lower HDL cholesterol and indirectly decreases HDL size. Plasma cholesterol esterification is unaltered or increased, whereas cholesteryl ester transfer is enhanced in type 2 diabetes mellitus, abnormalities which are probably related to the degree of hypertriglyceridaemia. It is plausible that a low LPL activity contributes to premature atherosclerosis as observed in insulin resistance and type 2 diabetes mellitus, but the effects of high HL activity and altered plasma cholesterol esterification on atherosclerosis development are uncertain. Since the cholesteryl ester transfer process between lipoproteins provides a metabolic intermediate between low HDL cholesterol and high plasma triglycerides, hypertriglyceridaemia-associated accelerated transfer of cholesteryl ester out of HDL may be pathogenetically involved in the development of cardiovascular disease in insulin resistance and type 2 diabetes mellitus.
Similar articles
-
Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.Eur J Clin Invest. 2003 Dec;33(12):1051-69. doi: 10.1111/j.1365-2362.2003.01263.x. Eur J Clin Invest. 2003. PMID: 14636288 Review.
-
Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.Atherosclerosis. 1998 Sep;140(1):71-9. doi: 10.1016/s0021-9150(98)00111-7. Atherosclerosis. 1998. PMID: 9733217
-
Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.Biochemistry. 2004 Nov 23;43(46):14811-20. doi: 10.1021/bi0485629. Biochemistry. 2004. PMID: 15544352
-
Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.Diabetologia. 1998 Aug;41(8):929-34. doi: 10.1007/s001250051009. Diabetologia. 1998. PMID: 9726595
-
CETP inhibition in cardiovascular risk management: a critical appraisal.Eur J Clin Invest. 2007 Feb;37(2):90-8. doi: 10.1111/j.1365-2362.2007.01756.x. Eur J Clin Invest. 2007. PMID: 17217373 Review.
Cited by
-
Associations of Abdominal and Cardiovascular Adipose Tissue Depots With HDL Metrics in Midlife Women: the SWAN Study.J Clin Endocrinol Metab. 2022 May 17;107(6):e2245-e2257. doi: 10.1210/clinem/dgac148. J Clin Endocrinol Metab. 2022. PMID: 35298649 Free PMC article.
-
The Marine Microalga, Tisochrysis lutea, Protects against Metabolic Disorders Associated with Metabolic Syndrome and Obesity.Nutrients. 2021 Jan 28;13(2):430. doi: 10.3390/nu13020430. Nutrients. 2021. PMID: 33525643 Free PMC article.
-
Effect of Carotenoids from Phaeodactylum tricornutum on Palmitate-Treated HepG2 Cells.Molecules. 2020 Jun 19;25(12):2845. doi: 10.3390/molecules25122845. Molecules. 2020. PMID: 32575640 Free PMC article.
-
Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.Curr Diab Rep. 2018 Oct 17;18(12):127. doi: 10.1007/s11892-018-1101-6. Curr Diab Rep. 2018. PMID: 30328521 Free PMC article. Review.
-
Pre-heparin lipoprotein lipase mass as a potential mediator in the association between adiponectin and HDL-cholesterol in type 2 diabetes.J Clin Transl Endocrinol. 2016 Dec 10;7:7-11. doi: 10.1016/j.jcte.2016.12.002. eCollection 2017 Mar. J Clin Transl Endocrinol. 2016. PMID: 29067244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous